OBJECTIVES: To derive age and sex specific estimates of transition rates from advanced adenomas to colorectal cancer by combining data of a nationwide screening colonoscopy registry and national data on colorectal cancer (CRC) incidence. DESIGN: Registry based study. SETTING: National screening colonoscopy programme in Germany. PATIENTS: Participants of screening colonoscopy in 2003 and 2004 (n = 840,149). MAIN OUTCOME MEASURES: Advanced adenoma prevalence, colorectal cancer incidence, annual and 10 year cumulative risk of developing CRC among carriers of advanced adenomas according to sex and age (range 55-80+ years) RESULTS: The age gradient is much stronger for CRC incidence than for advanced adenoma prevalence. As a result, projected annual transition rates from advanced adenomas to CRC strongly increase with age (from 2.6% in age group 55-59 years to 5.6% in age group >or=80 years among women, and from 2.6% in age group 55-59 years to 5.1% in age group >or=80 years among men). Projections of 10 year cumulative risk increase from 25.4% at age 55 years to 42.9% at age 80 years in women, and from 25.2% at age 55 years to 39.7% at age 80 years in men. CONCLUSIONS: Advanced adenoma transition rates are similar in both sexes, but there is a strong age gradient for both sexes. Our estimates of transition rates in older age groups are in line with previous estimates derived from small case series in the pre-colonoscopy era independent of age. However, our projections for younger age groups are considerably lower. These findings may have important implications for the design of CRC screening programmes.
OBJECTIVES: To derive age and sex specific estimates of transition rates from advanced adenomas to colorectal cancer by combining data of a nationwide screening colonoscopy registry and national data on colorectal cancer (CRC) incidence. DESIGN: Registry based study. SETTING: National screening colonoscopy programme in Germany. PATIENTS: Participants of screening colonoscopy in 2003 and 2004 (n = 840,149). MAIN OUTCOME MEASURES: Advanced adenoma prevalence, colorectal cancer incidence, annual and 10 year cumulative risk of developing CRC among carriers of advanced adenomas according to sex and age (range 55-80+ years) RESULTS: The age gradient is much stronger for CRC incidence than for advanced adenoma prevalence. As a result, projected annual transition rates from advanced adenomas to CRC strongly increase with age (from 2.6% in age group 55-59 years to 5.6% in age group >or=80 years among women, and from 2.6% in age group 55-59 years to 5.1% in age group >or=80 years among men). Projections of 10 year cumulative risk increase from 25.4% at age 55 years to 42.9% at age 80 years in women, and from 25.2% at age 55 years to 39.7% at age 80 years in men. CONCLUSIONS: Advanced adenoma transition rates are similar in both sexes, but there is a strong age gradient for both sexes. Our estimates of transition rates in older age groups are in line with previous estimates derived from small case series in the pre-colonoscopy era independent of age. However, our projections for younger age groups are considerably lower. These findings may have important implications for the design of CRC screening programmes.
Authors: F Loeve; M L Brown; R Boer; M van Ballegooijen; G J van Oortmarssen; J D Habbema Journal: J Natl Cancer Inst Date: 2000-04-05 Impact factor: 13.506
Authors: Erica K Barnell; Yiming Kang; Andrew R Barnell; Kimberly R Kruse; Jared Fiske; Zachary R Pittz; Adnan R Khan; Thomas A Huebner; Faith L Holmes; Malachi Griffith; Obi L Griffith; Aadel A Chaudhuri; Elizabeth M Wurtzler Journal: Clin Transl Gastroenterol Date: 2021-05-24 Impact factor: 4.488
Authors: H Kamiyama; K Suzuki; T Maeda; K Koizumi; Y Miyaki; S Okada; Y J Kawamura; J K Samuelsson; S Alonso; F Konishi; M Perucho Journal: Oncogene Date: 2012-02-06 Impact factor: 9.867
Authors: Hamzah Abu-Sbeih; Ellie Chen; Osman Ahmed; Niharika Mallepally; Phillip Lum; Wei Qiao; Hun Ju Lee; Robert Bresalier; Lan Sun Wang; Brian Weston; Gottumukkala S Raju; Yinghong Wang Journal: Dig Dis Sci Date: 2019-05-03 Impact factor: 3.199
Authors: Myron Arlen; Philip Arlen; Gene Coppa; Jim Crawford; XuePing Wang; Olga Saric; Alex Dubeykovskiy; Ernesto Molmenti Journal: World J Gastrointest Oncol Date: 2014-06-15